iPhone | iPad
Android
Huawei
Some schools have told students to stay home for the rest of the week, while thousands of residents of low-lying areas have been evacuated
KT APPDOWNLOAD
US FDA approves first nasal spray for allergic reactions
The spray was approved for use in adult and pediatric patients who weigh at least 30 kilograms
Representational image
The US Food and Drug Administration said on Friday it had approved ARS Pharmaceuticals' nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
The spray, which will be sold under the brand name neffy, was approved for use in adult and pediatric patients who weigh at least 30 kilograms.
Neffy is seen as an alternative to EpiPen and other autoinjectors like Kaleo's Auvi-Q that are filled with epinephrine, a life-saving drug used by people at risk of anaphylaxis and other allergic reactions.
Shares of ARS Pharmaceuticals rose about 3% after the FDA's decision.
ALSO READ:
More news from World
The lawmakers will remain in custody until September 18 for investigation
Swift broke her silence and voiced support for Harris over Donald Trump, calling the Democratic candidate a 'steady-handed, gifted leader'
Parliament has never had more than seven per cent women lawmakers
The vice-president maintained an expressive face throughout the evening, raising her eyebrows, laughing, and looking on as if in disbelief as Trump spoke
Pezeshkian was sworn in as Iran's new president in July
Harris made a point to get under Trump's skin, as her campaign had forecast — and it worked
Social media is playing an even more significant role in this year's election cycle than it has in the past, political strategists say